Publicaciones en las que colabora con María Socorro Espuelas Millán (31)

2024

  1. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

2023

  1. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

2022

  1. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  2. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

  3. Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  4. New amides and phosphoramidates containing selenium: Studies on their cytotoxicity and antioxidant activities in breast cancer

    Antioxidants, Vol. 10, Núm. 4

  5. New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  6. New phosphoramidates containing selenium as leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10

  7. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

  8. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18

  2. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates

    Bioorganic and Medicinal Chemistry Letters, Vol. 30, Núm. 17

  3. Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity

    Journal of Medicinal Chemistry, Vol. 63, Núm. 8, pp. 4306-4314

2019

  1. Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

    Pharmaceutics, Vol. 11, Núm. 11

  2. Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5

2018

  1. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

    Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88

2017

  1. Library of seleno-compounds as novel agents against Leishmania species

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 6